UBS Adjusts Expeditors International of Washington Price Target to $220 From $210, Maintains Buy Rating

UBS raised its price target for Expeditors International of Washington from $210 to $220 while maintaining a buy rating. The stock is currently trading at $191.93, up 2.23% on the day and 28.95% year-to-date.

Original reporting
Published Oct 2, 2026, 2:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 2:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$EXPD
Bullish
high confidence
Mentioned
$EXPD
Relevance
6/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$EXPDBullishMed
01

Why it matters

The upgrade may attract short-term buying interest and could trigger a modest price rally.

02

Market read

Analyst target revisions are a common short-term catalyst for stock movement.

03

What to watch

Potential headwinds from rising fuel costs and supply-chain disruptions.

Relevance 6/10Novelty 5/10Timing: today

Background

UBS issued a new composite rating and adjusted its valuation assumptions, resulting in a higher price target.

Company-level read

Ticker impact

$EXPDBullishHigh confidence
Context

UBS raised Expeditors International's price target to $220 from $210.

Expected impact

potential upward pressure as investors price in the higher target

Evidence & confidence

Analyst target upgrades are a direct catalyst that can move the stock in the short term.

Market effects

May lift sentiment for the logistics and freight forwarding sector.

Limited to U.S. markets where EXPD trades.

Minimal global impact beyond sector peers.

Counterpoint

Target raise could be premature if macro freight demand softens.

Key entities

  • UBS

    Provides the price target upgrade.

  • Expeditors International of Washington

    Subject of the price target change.

Related articles

$AZNHighAI 8/10

AstraZeneca, Leidos, Expeditors International: CNBC ‘Final Trades’ - Expeditors International (NYSE:EXPD)

CNBC's 'Final Trades' featured picks from Jim Lebenthal (AstraZeneca, AZN), Stephen Weiss (Leidos, LDOS), Liz Thomas (Treasuries), and Joseph Terranova (Expeditors, EXPD). AZN reported regulatory approvals and strong trial data, LDOS beat Q2 estimates and raised guidance, and EXPD also exceeded Q2 expectations. Shares of AZN, LDOS, and EXPD rose 2.3%, 3.1%, and 0.5% respectively on Monday.

$EXPDHighAI 8/10

Expeditors (EXPD) Posts A 51% Earnings Jump, But Some Of It Won’t Last

Expeditors International (EXPD) reported Q2 2026 earnings, with EPS up 51% to $2.03, net earnings up 45% to $266M, and revenue up 32% to $3.5B. Growth was seen across all segments, including airfreight and ocean freight. The company returned $461M to shareholders and announced a $25M restructuring. Some growth factors, like air freight rates and customs filings, may be temporary.

$UPSMedAI 8/10

Q2 Earnings Outperformers: United Parcel Service (NYSE:UPS) And The Rest Of The Air Freight and Logistics Stocks

United Parcel Service (UPS) reported Q2 revenue of $22.83B, up 7.6% YoY, beating estimates by 4.4%. Expeditors (EXPD) saw 32.1% revenue growth, outperforming estimates by 18.6%. FedEx (FDX) reported 12.5% growth, missing EPS guidance. C.H. Robinson (CHRW) grew 19.3%, beating estimates by 12.7%. Air freight stocks collectively beat revenue estimates by 10% but declined 3.4% in share price since earnings.